{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:06:58Z","timestamp":1788336418079,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001946","name":"American Skin Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000179","name":"Office of the Director","doi-asserted-by":"publisher","award":["CA009338"],"award-info":[{"award-number":["CA009338"]}],"id":[{"id":"10.13039\/100000179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000179","name":"Office of the Director","doi-asserted-by":"publisher","award":["OD010429"],"award-info":[{"award-number":["OD010429"]}],"id":[{"id":"10.13039\/100000179","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jid.2019.01.033","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T11:59:21Z","timestamp":1552391961000},"page":"1966-1974.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Preclinical Targeting of MicroRNA-214 in Cutaneous T-Cell Lymphoma"],"prefix":"10.1016","volume":"139","author":[{"given":"Rebecca","family":"Kohnken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betina","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Grinshpun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashleigh","family":"Keiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basem","family":"William","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Porcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2019.01.033_bib1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1073\/pnas.1422165112","article-title":"An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma","volume":"112","author":"Baratta","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2019.01.033_bib2","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.ijcard.2012.12.094","article-title":"TWIST1 regulates the activity of ubiquitin proteasome system via the miR-199\/214 cluster in human end-stage dilated cardiomyopathy","volume":"168","author":"Baumgarten","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jid.2019.01.033_bib3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrc3256","article-title":"BET domain co-regulators in obesity, inflammation and cancer","volume":"12","author":"Belkina","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2019.01.033_bib4","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jid.2016.01.038","article-title":"Evaluation of immunophenotypic and molecular biomarkers for S\u00e9zary syndrome using standard operating procedures: a multicenter study of 59 patients","volume":"136","author":"Boonk","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2019.01.033_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/1541-7786.MCR-12-0456","article-title":"Inhibition of TWIST1 leads to activation of oncogene-induced senescence in oncogene-driven non-small cell lung cancer","volume":"11","author":"Burns","year":"2013","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jid.2019.01.033_bib6","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1038\/srep06413","article-title":"A\u00a0miR-199a\/miR-214 self-regulatory network via PSMD10, TP53 and DNMT1 in testicular germ cell tumor","volume":"4","author":"Chen","year":"2014","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jid.2019.01.033_bib7","doi-asserted-by":"crossref","first-page":"G491","DOI":"10.1152\/ajpgi.00140.2015","article-title":"Suppression of fibrogenic signaling in hepatic stellate cells by Twist1-dependent microRNA-214 expression: role of exosomes in horizontal transfer of Twist1","volume":"309","author":"Chen","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jid.2019.01.033_bib8","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1158\/1078-0432.CCR-12-3066","article-title":"Inhibition of BET bromodomain targets genetically diverse glioblastoma","volume":"19","author":"Cheng","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2019.01.033_bib9","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2019.01.033_bib10","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3892\/or.2015.4410","article-title":"JQ1, an inhibitor of the epigenetic reader BRD4, suppresses the bidirectional MYC-AP4 axis via multiple mechanisms","volume":"35","author":"Choi","year":"2016","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jid.2019.01.033_bib11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jcma.2015.05.002","article-title":"Epithelial-mesenchymal transition-related factors in solid tumor and hematological malignancy","volume":"78","author":"Chou","year":"2015","journal-title":"J\u00a0Chin Med Assoc"},{"key":"10.1016\/j.jid.2019.01.033_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/2229-3485.179431","article-title":"MicroRNA therapeutics: discovering novel targets and developing specific therapy","volume":"7","author":"Christopher","year":"2016","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.jid.2019.01.033_bib13","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1182\/blood-2009-11-254680","article-title":"Deregulation of TWIST-1 in the CD34+ compartment represents a novel prognostic factor in chronic myeloid leukemia","volume":"117","author":"Cosset","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jid.2019.01.033_bib14","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous T cell lymphoma and S\u00e9zary syndrome","volume":"47","author":"da Silva Almeida","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2019.01.033_bib15","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jid.2019.01.033_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood-2006-06-025999","article-title":"Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)","volume":"109","author":"Duvic","year":"2007","journal-title":"Blood"},{"issue":"7327","key":"10.1016\/j.jid.2019.01.033_bib17","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jid.2019.01.033_bib18","doi-asserted-by":"crossref","first-page":"382745","DOI":"10.1155\/2015\/382745","article-title":"RNA-based TWIST1 inhibition via dendrimer complex to reduce breast cancer cell metastasis","volume":"2015","author":"Finlay","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jid.2019.01.033_bib19","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1038\/onc.2015.394","article-title":"Tumour-suppression function of KLF12 through regulation of anoikis","volume":"35","author":"Godin-Heymann","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2019.01.033_bib20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1600-0560.2012.01883.x","article-title":"Increased Twist expression in advanced stage of mycosis fungoides and S\u00e9zary syndrome","volume":"39","author":"Goswami","year":"2012","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jid.2019.01.033_bib21","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.18632\/oncotarget.733","article-title":"Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia (AML)","volume":"3","author":"Herrmann","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2019.01.033_bib22","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4049\/jimmunol.1000793","article-title":"Costimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten","volume":"185","author":"Jindra","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2019.01.033_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.stem.2014.12.005","article-title":"Unraveling the TWIST between EMT and cancer stemness","volume":"16","author":"Jung","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jid.2019.01.033_bib24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2217\/epi.14.91","article-title":"Targeting\u00a0BET bromodomains for cancer treatment","volume":"7","author":"Jung","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.jid.2019.01.033_bib25","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.1038\/ncomms9470","article-title":"Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in S\u00e9zary syndrome","volume":"6","author":"Kiel","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2019.01.033_bib26","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11899-016-0351-0","article-title":"S\u00e9zary syndrome: clinical and biological aspects","volume":"11","author":"Kohnken","year":"2016","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.jid.2019.01.033_bib27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1182\/blood-2017-09-805663","article-title":"Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma","volume":"131","author":"Kohnken","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jid.2019.01.033_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/nar\/gkn920","article-title":"Twist-1 regulates the miR-199a\/214 cluster during development","volume":"37","author":"Lee","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2019.01.033_bib29","doi-asserted-by":"crossref","first-page":"8239","DOI":"10.1007\/s13277-015-4708-0","article-title":"MiR-214 suppressed ovarian cancer and negatively regulated semaphorin 4D","volume":"37","author":"Liu","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jid.2019.01.033_bib30","doi-asserted-by":"crossref","first-page":"19408","DOI":"10.1073\/pnas.1216363109","article-title":"Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins","volume":"109","author":"Lockwood","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2019.01.033_bib31","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1182\/blood-2014-11-611194","article-title":"Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides","volume":"126","author":"McGirt","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jid.2019.01.033_bib32","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1182\/blood-2012-10-460535","article-title":"Use of PLS3, Twist, CD158k\/KIR3DL2, and NKp46 gene expression combination for reliable S\u00e9zary syndrome diagnosis","volume":"121","author":"Michel","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jid.2019.01.033_bib33","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1158\/2159-8290.CD-15-1297","article-title":"Mechanism, consequences and therapeutic targeting of abnormal IL-15 signaling in cutaneous T-cell lymphoma","volume":"6","author":"Mishra","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2019.01.033_bib34","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3324\/haematol.2012.070011","article-title":"Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication","volume":"98","author":"Misiewicz-Krzeminska","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jid.2019.01.033_bib35","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/ijc.24538","article-title":"Kr\u00fcppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression","volume":"125","author":"Nakamura","year":"2009","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.jid.2019.01.033_bib36","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1038\/cddis.2011.32","article-title":"MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in S\u00e9zary syndrome","volume":"2","author":"Narducci","year":"2011","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jid.2019.01.033_bib37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1615\/CritRevImmunol.2013006858","article-title":"MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development","volume":"33","author":"Podshivalova","year":"2013","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.jid.2019.01.033_bib38","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/jid.2011.481","article-title":"Deep-sequencing analysis reveals that the miR-199a2\/214 cluster within DNM3os represents the vast majority of aberrantly expressed microRNAs in S\u00e9zary syndrome","volume":"132","author":"Qin","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2019.01.033_bib39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jid.2019.01.033_bib40","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/jid.2009.306","article-title":"Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides","volume":"130","author":"Salgado","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2019.01.033_bib41","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1182\/blood.V126.23.2758.2758","article-title":"Preclinical results supporting therapeutic development of Mrg-106, an oligonucleotide inhibitor of Mir-155, in CTCL","volume":"126","author":"Seto","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jid.2019.01.033_bib42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2217\/fon.14.193","article-title":"miR-214: a potential biomarker and therapeutic for different cancers","volume":"11","author":"Sharma","year":"2015","journal-title":"Future Oncol"},{"key":"10.1016\/j.jid.2019.01.033_bib43","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2174\/1381612821666141211153853","article-title":"Twist-BRD4 complex: potential drug target for basal-like breast cancer","volume":"21","author":"Shi","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jid.2019.01.033_bib44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ccr.2014.01.028","article-title":"Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer","volume":"25","author":"Shi","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2019.01.033_bib45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1086\/685079","article-title":"Regulation and function of miR-214 in pulmonary arterial hypertension","volume":"6","author":"Stevens","year":"2016","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jid.2019.01.033_bib46","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood-2015-04-639542","article-title":"Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib","volume":"126","author":"Sun","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jid.2019.01.033_bib47","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc3582","article-title":"Kr\u00fcppel-like factors in cancer","volume":"13","author":"Tetreault","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2019.01.033_bib48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7314\/APJCP.2012.13.1.255","article-title":"MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN\/AKT pathway in EGFR-mutant cell lines","volume":"13","author":"Wang","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jid.2019.01.033_bib49","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1200\/JCO.2010.28.9066","article-title":"Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma","volume":"28","author":"Whittaker","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2019.01.033_bib50","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1038\/jid.2015.116","article-title":"Promoter-specific hypomethylation is associated with overexpression of PLS3, GATA6, and TWIST1 in the S\u00e9zary syndrome","volume":"135","author":"Wong","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2019.01.033_bib51","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2141.2011.08852.x","article-title":"Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and S\u00e9zary syndrome)","volume":"155","author":"Wong","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jid.2019.01.033_bib52","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/0008-5472.CAN-07-2488","article-title":"MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2019.01.033_bib53","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1475-2867-13-68","article-title":"MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN","volume":"13","author":"Yang","year":"2013","journal-title":"Cancer Cell Int"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X19313260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X19313260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:44:15Z","timestamp":1762206255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X19313260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0022202X19313260"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2019.01.033","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical Targeting of MicroRNA-214 in Cutaneous T-Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2019.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}